Table 1 Baseline characteristics of 3 groups
Variable	Tertile 1 (n=844)	Tertile 2 (n=843)	Tertile 3 (n=844)	P value	
Age, years	66.4±6.8	66.6±6.7	66.0±6.9	0.187	
Male	479(56.8)	467(55.4)	469(55.6)	0.830	
Duration of diabetes, years	10.0±7.6	10.0±8.1	9.5±7.3	0.230	
Newly diagnosed diabetes	51(6.0)	52(6.2)	54(6.4)	0.954	
Smoker 	331(39.2)	347(41.2)	321(38.0)	0.414	
Hypertension 	652(77.3)	660(78.3)	632(74.9)	0.235	
Family history of CAD 	83(9.8)	86(10.2)	102(12.1)	0.276	
Previous MI 	103(12.2)	96(11.4)	109(12.9)	0.631	
Previous PCI 	190(22.5)	148(17.6)	160(19.0)	0.031	
Previous CABG 	33(3.9)	36(4.3)	33(3.9)	0.910	
Previous stroke	149(17.7)	183(21.7)	183(21.7)	0.059	
BMI, kg/m2	25.7±2.9	26.0±3.0	26.1±2.8	0.015	
LVEF	58±8	58±8	59±9	0.619	
Clinical presentation				0.021	
 UAP	650(77.0)	673(79.8)	695(82.3)		
 NSTEMI	92(10.9)	75(8.9)	83(9.8)		
 STEMI	102(12.1)	95(11.3)	66(7.9)		
Left main disease	84(10.0)	87(10.3)	92(10.9)	0.813	
Multi-vessel disease	676(80.1)	681(80.8)	687(81.4)	0.819	
Treatment strategy				0.432	
  Intensive medicine	278(32.9)	263(31.2)	259(30.7)		
PCI
CABG
Laboratory findings
FBG, mmol/L,
  HbA1c, %
TC, mmol/L
TG, mmol/L
LDL-C, mmol/L 
HDL-C, mmol/L
AIP
Uric acid, umol/L
hs-CRP, mg/L	483(57.2)
83(9.9)

8.0±3.1
7.5±1.3
4.55±1.11
0.95(0.77-1.14)
2.95±0.98
1.23±0.31
-0.079±0.117
299.2±86.1
1.22(0.56-4.12)	474(56.2)
106(12.6)

7.9±2.8
7.7±1.4
4.46±1.08
1.30(1.11-1.56)
2.94±0.96
1.05±0.24
0.167±0.059
314.0±89.3
1.84(0.74-5.07)	490(58.1)
95(11.2)

8.1±3.2
7.8±1.5
4.25±1.16
1.72(1.45-2.03)
2.80±0.90
0.92±0.24
0.450±0.150
324.1±98.8
1.94(0.85-5.10)	

0.371
<0.001
<0.001
<0.001
0.002
<0.001
<0.001
<0.001
<0.001	

Table 1 (continued)
Variable	Tertile 1 (n=844)	Tertile 2 (n=843)	Tertile 3 (n=844)	P value	
NT-proBNP, pg/ml	142.5(85.1-237.0)	119.4(83.1-233.1)	135.3(83.2-232.5)	0.257	
eGFR, mL/min	94.2±23.5	94.0±23.7	91.2±23.9	0.014	
Medications at discharge					
  Aspirin	814(96.4)	813(96.4)	815(96.6)	0.988	
Clopidogrel/Ticagrelor	675(80.0)	681(80.8)	706(83.6)	0.125	
β-blocker	541(64.1)	532(63.9)	571(67.7)	0.120	
ACEI/ARB	487(57.7)	475(56.3)	483(57.2)	0.850	
Statin	800(94.8)	807(95.7)	799(94.7)	0.545	
CCB	235(27.8)	241(28.6)	249(29.5)	0.752	
Nitrate	464(55.0)	467(55.4)	459(54.4)	0.915	
Insulin	354(41.9)	343(40.7)	328(38.9)	0.432	
Data are expressed as mean ± SD, medians with interquartile ranges or percentage.
MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, BMI body mass index, LVEF left ventricle ejection fraction, UAP unstable angina pectoris, NSTEMI non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction, FBG fasting blood glucose, HbA1c Hemoglobin A1c, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AIP atherogenic index of plasma, hs-CRP high-sensitivity C-reactive protein, NT-proBNP  N-terminal proB-type natriuretic peptide, eGFR estimated glomerular filtration rate, ACEI angiotensin II coenzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker; SD, standard deviation.